212 related articles for article (PubMed ID: 21412930)
21. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
Tang S; Luo H; Yu J; Yang D; Shu J
Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
[TBL] [Abstract][Full Text] [Related]
22. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines.
Zhang H; Chen ZH; Savarese TM
Cancer Genet Cytogenet; 1996 Jan; 86(1):22-8. PubMed ID: 8616780
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S
Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769
[TBL] [Abstract][Full Text] [Related]
24. Methylthioadenosine phosphorylase inactivation depends on gene deletion in laryngeal squamous cell carcinoma.
Conde L; Vilaseca I; Alós L; Bernal-Sprekelsen M; Cardesa A; Nadal A
Histopathology; 2012 Dec; 61(6):1082-8. PubMed ID: 23020581
[TBL] [Abstract][Full Text] [Related]
25. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
[TBL] [Abstract][Full Text] [Related]
26. Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.
Sasaki S; Takeda M; Hirose T; Fujii T; Itami H; Uchiyama T; Morita K; Matsuda R; Yamada S; Nakagawa I; Ohbayashi C
J Neuropathol Exp Neurol; 2022 Jan; 81(2):117-126. PubMed ID: 34897475
[TBL] [Abstract][Full Text] [Related]
27. Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma.
Chapel DB; Dubuc AM; Hornick JL; Sholl LM
Histopathology; 2021 Jun; 78(7):1032-1042. PubMed ID: 33387364
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.
Kim J; Kim MA; Jee CD; Jung EJ; Kim WH
Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876
[TBL] [Abstract][Full Text] [Related]
29. [Deletion and down-regulation of mts1/p16 gene in human gastric cancer].
Lu Y; Gao C; Cui J
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):189-91. PubMed ID: 9387251
[TBL] [Abstract][Full Text] [Related]
30. Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells.
Efferth T; Miyachi H; Drexler HG; Gebhart E
Blood Cells Mol Dis; 2002; 28(1):47-56. PubMed ID: 11987241
[TBL] [Abstract][Full Text] [Related]
31. Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers.
Karikari CA; Mullendore M; Eshleman JR; Argani P; Leoni LM; Chattopadhyay S; Hidalgo M; Maitra A
Mol Cancer Ther; 2005 Dec; 4(12):1860-6. PubMed ID: 16373701
[TBL] [Abstract][Full Text] [Related]
32. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Sakakura C; Mitsufuji S; Hirohashi S; Inazawa J
Oncogene; 2006 Oct; 25(49):6554-62. PubMed ID: 16715143
[TBL] [Abstract][Full Text] [Related]
33. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
Subhi AL; Tang B; Balsara BR; Altomare DA; Testa JR; Cooper HS; Hoffman JP; Meropol NJ; Kruger WD
Clin Cancer Res; 2004 Nov; 10(21):7290-6. PubMed ID: 15534104
[TBL] [Abstract][Full Text] [Related]
34. Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
de Oliveira SF; Ganzinelli M; Chilà R; Serino L; Maciel ME; Urban Cde A; de Lima RS; Cavalli IJ; Generali D; Broggini M; Damia G; Ribeiro EM
PLoS One; 2016; 11(1):e0145647. PubMed ID: 26751376
[TBL] [Abstract][Full Text] [Related]
35. Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma.
Lou L; Li J; Qin M; Tian X; Guo W; Li Y
Brain Tumor Pathol; 2023 Jan; 40(1):15-25. PubMed ID: 36550382
[TBL] [Abstract][Full Text] [Related]
36. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.
Hustinx SR; Hruban RH; Leoni LM; Iacobuzio-Donahue C; Cameron JL; Yeo CJ; Brown PN; Argani P; Ashfaq R; Fukushima N; Goggins M; Kern SE; Maitra A
Cancer Biol Ther; 2005 Jan; 4(1):83-6. PubMed ID: 15662124
[TBL] [Abstract][Full Text] [Related]
37. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5.
Mavrakis KJ; McDonald ER; Schlabach MR; Billy E; Hoffman GR; deWeck A; Ruddy DA; Venkatesan K; Yu J; McAllister G; Stump M; deBeaumont R; Ho S; Yue Y; Liu Y; Yan-Neale Y; Yang G; Lin F; Yin H; Gao H; Kipp DR; Zhao S; McNamara JT; Sprague ER; Zheng B; Lin Y; Cho YS; Gu J; Crawford K; Ciccone D; Vitari AC; Lai A; Capka V; Hurov K; Porter JA; Tallarico J; Mickanin C; Lees E; Pagliarini R; Keen N; Schmelzle T; Hofmann F; Stegmeier F; Sellers WR
Science; 2016 Mar; 351(6278):1208-13. PubMed ID: 26912361
[TBL] [Abstract][Full Text] [Related]
38. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma.
Satomi K; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Narita Y; Ichimura K; Yoshida A
Mod Pathol; 2021 Apr; 34(4):688-700. PubMed ID: 33077924
[TBL] [Abstract][Full Text] [Related]
39. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
[TBL] [Abstract][Full Text] [Related]
40. Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma?
Nishikubo M; Jimbo N; Tanaka Y; Tachihara M; Itoh T; Maniwa Y
Virchows Arch; 2022 Aug; 481(2):307-312. PubMed ID: 35043235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]